亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台,协助业界发掘知识产权贸易商机,并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权,或是制造商需要购买技术以提高操作效能,又或是知识产权配套服务供应商,你将会从本网站发掘到有用的知识产权贸易资讯。

A Cell-Based Seeding Assay for Huntingtin Aggregation

技术优势
SpecificSensitiveHigh throughputCorrelates with disease progressionCompatible with biological samples
技术应用
Huntington's Disease diagnosis Drug discoveryClinical trial biomarker
详细技术说明
A novel high throughput cell-based seeding assay was developed to detect mutant HTT proteins. This approach utilizes a transgenic cell line that expresses a form of mHTT, which is linked to a green fluorescent protein (GFP), making any aggregates easily quantifiable. The cell line has a very low baseline level of aggregates. However, it can be highly specifically induced to form aggregates with even very small aggregate seeds are introduced from HD patients or mouse samples. The readout correlates well with the amount of seeds added and with the disease stage of the HD patients.
*Abstract
UCLA researchers from the Department of Psychiatry has created a novel cell-based seeding assay for sensitive, specific and high throughput detection of mutant Huntingtin proteins in biological samples.
*Principal Investigation

Name: Chung-Ying Lee

Department:


Name: Nan Wang

Department:


Name: Xiangdong Yang

Department:

其他

Background

Huntington’s disease (HD) is a lethal genetic disorder that is caused by mutatations in thehuntingtin protein (mHTT). Genetic errors cause an elongated repeat motif to result in a polyglutamine (polyQ) stretch in the expressed protein, causing it to form aggregates. These aggregates accumulate in the nerve cells eventually lead to their breakdown, incurring debilitating effects. Current molecular methods of diagnosing HD include direct detection, in vitro aggregation detection and cell based detection. Direct detection of HTT uses antibodies, which can only detect a subset of HTT in soluble, monomer forms. In vitro aggregation detection lacks sensitivity. Other existing cell based detection approaches are prone to false positives and are labor intensive.


Additional Technologies by these Inventors


Tech ID/UC Case

29135/2018-193-0


Related Cases

2018-193-0

国家/地区
美国

欲了解更多信息,请点击 这里
移动设备